TCR2 Therapeutics (NASDAQ:TCRR) reported its Q1 earnings results on Thursday, May 11, 2023 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
TCR2 Therapeutics missed estimated earnings by 51.47%, reporting an EPS of $-1.03 versus an estimate of $-0.68.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.77 which was followed by a 5.63% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for TCR2 Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.